These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3520039)

  • 21. [Calcium antagonist enhances the effect of adriamycin].
    Matsuoka H; Ueo H; Sugimachi K; Kai H; Matsuura H
    Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):508. PubMed ID: 4000105
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemodynamic effects of nicardipine in acute myocardial infarction.
    Silke B; Verma SP; Hafizullah M; Reynolds G; Frais MA; Jackson NC; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():29-34. PubMed ID: 6527977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of nicardipine on pituitary hormone release in normal volunteers.
    Isles TE; Baty J; Dow RJ
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):84S-87S. PubMed ID: 3927960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nicardipine, nifedipine, verapamil, and diltiazem on urine volume, sodium and potassium excretion and plasma aldosterone levels in the rat.
    Rosenkranz RP; McClelland DL; Roszkowski AP
    Proc West Pharmacol Soc; 1984; 27():67-72. PubMed ID: 6494200
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study.
    Lahiri A; Robinson CW; Tovey J; Caruana MP; Kohli RS; Harlow BJ; Raftery EB
    Postgrad Med J; 1984; 60 Suppl 4():35-8. PubMed ID: 6527978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation of Ca2+ efflux from the heart to the concentration of Ca-channel blockers].
    Khmel'-Dunaĭ GN; Narushiavichus EV
    Biull Eksp Biol Med; 1985 Nov; 100(11):559-61. PubMed ID: 4063502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of hormonal effects of a single dose of nifedipine in healthy young men.
    Joffe BI; Lamprey JM; Shires R; Baker S; Viljoen M; Seftel HC
    J Cardiovasc Pharmacol; 1983; 5(4):700-2. PubMed ID: 6193371
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of arterial hypertension with a calcium-channel blocking agent, nicardipine hydrochloride].
    Cascone A; Ferrari F; Alaimo A; Daprati A; Cascone G
    Boll Chim Farm; 1985 May; 124(5):37S-42S. PubMed ID: 4052244
    [No Abstract]   [Full Text] [Related]  

  • 30. [Calcium antagonists and glycoregulation: dissociated effects of nicardipine on vascular tonus and insulin secretion].
    Marre M; Gauville C; Passa P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1661-6. PubMed ID: 3938238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats.
    Briede J; Stivriņa M; Stoldere D; Bisenieks E; Uldriķis J; Poikāns J; Makarova N; Duburs G
    Cell Biochem Funct; 2004; 22(4):219-24. PubMed ID: 15248181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemodynamics during induced hypotension with continuous administration of nicardipine].
    Fukusaki M; Miyako M; Fukui S; Haseba S; Gotoh Y
    Masui; 1986 Apr; 35(4):551-6. PubMed ID: 3747102
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of nicardipine in a hypertensive patient with diabetes mellitus.
    Sakata S; Miura K
    Clin Ther; 1984; 6(5):600-2. PubMed ID: 6478468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular Ca++ antagonist, HA1004: pharmacological properties different from those of nicardipine.
    Asano T; Hidaka H
    J Pharmacol Exp Ther; 1985 May; 233(2):454-8. PubMed ID: 3999029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Membrane transport of anticancer drugs--potentiation of antitumor effect by calcium modifiers and overcoming of drug-resistance].
    Tsuruo T
    Tanpakushitsu Kakusan Koso; 1983 May; 28(6):865-71. PubMed ID: 6611960
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of neuroleptanesthesia and surgical stress on the concentration of growth hormone and insulin in the human blood].
    Takiguchi M; Takazawa T; Kudo T; Kudo M; Oyama T
    Geka Chiryo; 1971 May; 24(5):577-84. PubMed ID: 5108986
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
    Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H
    Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute and chronic effects of a new calcium blocker, nicardipine, on renal hemodynamics in arterial hypertension].
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guédon J
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1642-6. PubMed ID: 3938234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in carbohydrate metabolism during the administration of progestational hormones].
    Vela P
    Rev Chil Obstet Ginecol; 1970; 35(2):40-9. PubMed ID: 5531975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.